CVR

ellieappa

If you had WBA, you got paid $11.45/share when they were bought by Sycamore Partners and there is a potential additional payout when VillageMD is sold. The second point is the reason why you still have WBA (now 931CVR013) in your portfolio.

salty0waldo

I follow ammonia loosely, mainly since its a customer on the industrial gas space. I do recognize UAN, CVR Partners, so they produce fertilizer (ammonia and ammonia nitrates). Historically they have been good at capital allocation but I thought from the last call they were issuing some soft guidance. I might be wrong so would have to check again. Last year they had a lot of inventory to work through (as they played catchup in 2021-2022). It is a LP so the payout is MASSIVE lol.

leomeng

It’ll price up to cash value but there’s a huge CVR attached. Very good chance the CVR portion goes to zero.

dvdmovie1

It looks like $65.6/sh cash and a CVR (contingent value right, something that often is given in biotech deals; if certain goals are reached by X date, you will get $x additional - in this case, the CVR might be worth *up to* $20.65) at closing. Then the stock will be delisted/no longer public.

xavras_wyzryn

ADVM bought by LLY Under the terms of the merger agreement, Lilly will commence a tender offer to acquire all of the outstanding shares of Adverum common stock for a per share price of (1) $3.56 per share in cash payable at closing plus (2) one non-transferrable contingent value right (CVR) that entitles the holder to receive up to an additional $8.91 per CVR in cash upon the achievement of two milestones described below, for total potential per share consideration of up to $12.47.

kpchicken3

No date indicated, therefore it's not a restraint. "UPON COMPLETION OF THE ARRANGEMENT, EACH ESSA COMMON SHARE WILL BE TRANSFERRED TO XENO THERAPEUTICS IN EXCHANGE FOR THE RIGHT TO RECEIVE CASH CONSIDERATION AND CVR." https://www.sec.gov/Archives/edgar/data/1633932/000110465925067597/tm2520238d1_8k.htm

Amaixyah

I think this could reach as high a $20 per share taking into account the potential for non-tradeable CVR. It’s basically free money! Any chance this drops under $14.50 at any point I’m scooping up some more shares

NRS35dxd

89Bio ($ETNB) was just acquired by Roche and total premium including CVR is around +120% best case scenario. Rest assured BP is looking at $VKTX.

trumpdiego

Market Summary > CVR Energy, Inc. 33.01 USD +2.54 (8.34%) today Given Uncle Ichan owns like most of this stock wouldn't that mean IEP should start pumping again?

BillyMcFarlend

I have a stock that could actually squeeze because of a corporate action and some esoteric structural changes (an actual catalyst) and can’t post because I don’t have enough karma. Meanwhile people on here saying everything is going to squeeze for absolutely no reason.  Stock is $FGF and they announced an ETH treasury transaction ($200 million on a $50 million market cap, cool but not the main thing). Creating a CVR trust where all the legacy assets will go and it won’t trade so anyone short will be forced to cover by 8/8/2025 at any price. Borrow rate is 75%. Can post more if anyone cares…

greytoc

Ahh - thanks for tha! Oh yes - that makes way more sense than what I thought. As I think about - aren't the shares cancelled? That's why it's cash settled and there are no CVR delivery.

SamRHughes

You don't get the CVR because you can't exercise the calls for shares anymore.

greytoc

The original infomemo on the corporate action states that options will not be adjusted to include delivery of the CVR. And that call holders must exercise the contract to get the shares and th CVR. [https://infomemo.theocc.com/infomemos?number=56841](https://infomemo.theocc.com/infomemos?number=56841)

SamRHughes

The memo says the option deliverable doesn't include the CVR.

greytoc

Just to add to what u/SamRHughes said - there is also a CVR but you have to exercise the contract. And your broker would need to know how to process it since the NSCC is no longer accepting exercise and assignment. It's broker-to-broker settlement. But - the CVR is for up to $3. So - with a $15 strike - it's not worth exercising.

Slaintesteph

I'm going to decline. I've only got 200 hundred shares so it's nothing. I don't understand the CVR so if anyone does please explain it. It seems if you decline you'll be rolled into it anyway if it goes through, not sure if you'll get the CVR. They didn't allow stockholders to vote on the merger so the only way to express an opinion is by declining and hoping they don't get enough people to tender their shares. I'm sure this is probably a done deal, but it just really annoyed me to see that The employee stock options that are out of the money will be worthless. Since the stock has dropped a lot, I'm sure most of the Employees options are out of the money. That seems like a really lousy thing to do to your employees. that's the main reason I'm declining. I don't really expect to ever make any money on this stock

UnhingedCorgi

They’re just not publicly saying who said it. They didn’t even release the full CVR transcript. 

dvdmovie1

I owned this and sold already. From the PR: "**The consummation of the tender offer is subject to customary closing conditions, including the tender of a number of shares of Blueprint common stock representing at least a majority of the outstanding shares of Blueprint common stock, the receipt of required regulatory approvals, and other customary conditions. If the tender offer is successfully completed, a wholly owned subsidiary of Sanofi will merge with and into Blueprint and all of the outstanding Blueprint shares that are not tendered in the tender offer will be converted into the right to receive the same $129.00 per share in cash and one CVR per share offered to Blueprint shareholders in the tender offer.** Sanofi plans to finance the transaction with a combination of cash on hand and proceeds from new debt. The tender offer is not subject to any financing condition. Subject to the satisfaction or waiver of customary closing conditions, Sanofi currently expects to complete the acquisition in the third quarter of 2025. The acquisition will not have a significant impact on Sanofi’s financial guidance for 2025. It is immediately accretive to gross margin and accretive to business operating income and EPS after 2026." There have been some instances in the past where what is required to complete the deal is to get a great majority of the outstanding shares and then anything left trading is eventually illiquid. You don't want that. Thermo Fisher buying Patheon several years ago was an example of this. They got 95.3% of the Patheon shares and then said by x date that Patheon was delisting. "Following delisting from the NYSE, Patheon ordinary shares will not be listed or registered on another national securities exchange. **Delisting is likely to reduce significantly the liquidity and marketability of any Patheon ordinary shares that have not been tendered pursuant to the tender offer.**" If something you own is bought, then unless you think a better offer is likely it's sell it and on to the next investment idea.

Yo_Biff

Agree with this. >Under the terms of the acquisition, Sanofi will pay $129.00 per share in cash at closing, representing an equity value of approximately $9.1 billion. Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) which will entitle the holder to receive two potential milestone payments of $2 and $4 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. Sanofi has entered into a definitive agreement to buy Blueprint Medicine, which means at some point there will be a vote by shareholders to accept or reject the offer. If the majority of shareholders vote to accept the offer, then all shareholders will be bought out at the agreed upon price. Given the jump in stock price at the beginning of the month, I would hazard to guess majority shareholders have already signaled they like the deal.

plannedgravy

> Maybe but it is starting to appear it was some failure and not necessarily Air accidents are rare for good reason. Layers and layers of safety and redundancy are stacked together so that no single failure can bring down the aircraft. Barring criminal negligence, there's almost always multiple unfortunate events that have had to happen in sequence for something like this to occur. The recent engine replacement and servicing certainly increases the likelihood of maintenance issues. I'm not sure the exacts on a 787, but there's at least triple redundancy for critical systems. That just makes a double engine flame-out so improbable. A fuel quality issue (which has brought down an airbus before) could certainly do it, but this was the only affected aircraft. But I don't think we will have to wait very long for a preliminary report. I think the FDR and CVR will be very telling in this incidence.

dvdmovie1

Looks like the company was bought in 2022: https://www.prnewswire.com/news-releases/indivior-completes-acquisition-of-opiant-pharmaceuticals-inc-301761055.html If it's a share, then I'd contact Fidelity to see why this wasn't cashed out. If it is a CVR, then that has a much longer holding period as noted in the above PR.

ehcanadianmoose

Yup. CVR (Cockpit Voice Recorder) will record all cockpit conversations, including transmitted and non-transmitted. FDR (Flight Data Recorder) will record all things airplane related, like condition of systems, positions of flight controls, and air-data to name a few. The Indian aviation authority will then piece together with local meteorology, maintenance history, SOPs, and anything else pertinent to build a more full picture. What was the configuration on takeoff? Weather? Was there an engine failure? Else? Why was the gear still extended after rotation? Were the pilots reacting to a non-normal situation and if so, what was their response? Lots of unknowns and lots of speculation on r/aviation. But in short, yes, with all the above you can piece together an informed picture of what may have led to today's tragic outcome.

ehcanadianmoose

Everything, unless complete power loss (i.e. dual-engine failure with no additional AC power source, like APU or RAT) causing CVR/FDR to become unpowered

dvdmovie1

Biotech is a very difficult sector to invest in both ways. There is a lot of crap, but there are great companies and I think there are companies working on important breakthroughs. The sector is fascinating and while difficult, can be really rewarding if you do well. If you don't have any medical background (or at the very least, invest long or short without really trying to understand the basics of the company) you can easily be long something that fails a trial and is down 80% in an instant or be short something that goes up 80% in an instant. People can overstay their welcome in a biotech short and then have something go up because of a buyout - RGLS is up massively this morning on a buyout for $7 + a $7 CVR. It was $1 and down 94% from 2021 at the start of this year. There was a story in 2015 where someone was short a biotech that Martin Shkreli bought a stake in (https://money.cnn.com/2015/11/20/investing/trader-gofundme-drug-kalobios-shkreli/index.html) and got absolutely obliterated - he was short at $2 and the stock opened at $16. So, I don't think that most biotech companies fail and drop dramatically in a couple of days. I think a lot don't work out, but even with that you have to be careful with shorts because you can have something down massively and then someone buys it and it could be up 100%+ in an instant, like the example above. IMO, you should absolutely have a strong thesis for investing long or short in anything, but biotech is a particularly big example of that. I like investing in biotech, but it's definitely not for everyone and a sector you have to be very careful with.

CreamyBehemoth

The only stock green on my watchlist is CVR. And it has 0 volume 

Strong_Land_9748

I bought about 1.7 k worth of CVR stock yesterday (with my own savings ofc) and after I bought it the price increased (look at first image for the price increase, second image for my position) later today I decided this had to be the worst f\*cking financial investment I have ever made and decided to sell. I sold and the price went down, I lost about 108 dollars but its worth the story (it really isn't, I am salting the wounds).

Strong_Land_9748

Bro... I bought CVR today as a Turk. I think this chilean might be unto something big

Skurttish

This post feels like either “I’ve done years of research and I’ve found the one company perfectly positioned to 1000x in the future” Or “my initials are CVR” 😂

ipurge123

Hello everyone, do you guys know where I can buy $CVR? Chicago revit & machine co? I can’t find a broker that sells it

SPAC_Time

[Gen Extends its Financial Wellness Offerings with the Acquisition of MoneyLion](https://www.prnewswire.com/news-releases/gen-extends-its-financial-wellness-offerings-with-the-acquisition-of-moneylion-302327494.html) \- ML [ML.WS](https://ML.WS) "The Board of Directors of both Gen and MoneyLion have unanimously approved the proposed acquisition of MoneyLion by Gen for $82.00 per share in cash payable at closing, representing a cash value of approximately $1 billion. In addition, for each share owned, MoneyLion shareholders will receive at closing one contingent value right ("CVR") that entitles the holder to a contingent payment of $23.00 in the form of shares of Gen common stock (issuable based on an assumed share price of $30.48 per Gen share) if Gen's average volume-weighted average share price reaches at least $37.50 per share over 30 consecutive trading days from December 10, 2024 until 24 months after close. There can be no assurance that any payments will be made with respect to CVRs. It is expected that the CVRs will be listed on the Nasdaq Stock Market."

DenseVegetable2581

This one will be pilot error. Interesting to hear what the CVR says, looks like straight up CFIT

joecool0909

Just curious what is this based on? Best search result I could find is CVR3 market timing.

Qzy

It takes me less than 5 minutes to get a CVR number and start selling in Denmark. What are you talking about?

drew-gen-x

I haven't bought any stocks in awhile because nothing seems really appealing at these valuations. Today I decided to open new positions in 2 boring stocks. 1 - $CVI which is one of Carl Icahn's bigger holdings. CVR energy is in the petroleum refining & nitrogen fertilizer producer. We'll see if their 8% dividend yield can hold up in a commodity bear market. 2 - $ABEV Ambev SA beer & pepsi distributer for Central & South America along with Canada. I don't usually like to buy penny stocks, but even in good & bad times people will still buy Budweiser, Corona, Modello, Pepsi & Mtn Dew. Plus I am looking to diversify outside of USA stocks. $ABEV currently has a 6% dividend yield but the dividend payment amount has been variable over the years and is only paid once annually.

Bossie81

Always sad when someone opposes a technical analysis with underbelly gibberish. Dispute the science. I dare you. Your first sentence, clearly indicates lack of deeper understanding. There is a good reason why I point out insurance. Besides, the TAM for MASH/NASH and effective GLP-1 and obesity drugs as a luxury globally leaves space for multiple candidates multiple indications. Further more, a partner is expected before the Phase 3 trial design meeting, or likely a CVR deal.

JonPonLongGone

Same, my position is from Progenics and we got the CVR payment and after researching I liked LNTH even more! Progenics had issues, and this is a great redemption story with great gains.

Right_Turnover_9755

Still no indication on the CVR conversion for old JWAC holders AFAIK. They certainly did not meet any of the criteria to give those bonus shares to Chijet and we are past the 30 day window for the annual report being filed (and not trading > $13). Wonder if the reverse stock split will convert those CVRs to new common stock Monday?

SPAC_Time

"(a) [In the event that it is finally determined in accordance with Section](https://www.sec.gov/Archives/edgar/data/1957413/000149315223009713/form424b3.htm#anne_001:~:text=In%20the%20event%20that%20it%20is%20finally%20determined%20in%20accordance%20with%20Section) 2.3(e) of the BCA that any of the Earnout Shares (and Earnings thereon) are no longer eligible to vest and must be surrendered by the Earnout Participants to Pubco for cancellation, and accordingly a payment (including by delivery of shares) will become due and payable to the holders of CVRs in accordance with the BCA and this Agreement (a “CVR Payment”), **Pubco will promptly (but in any event within ten (10) Business Days after such final determination) notify the Rights Agent in writing (a “CVR Payment Notice”)** of (i) the amount of Earnout Shares (or other securities or property surrendered as part of applicable Earnout Shares and Earnings thereon) that were surrendered by the Earnout Participants, which will be issued by Pubco as new Pubco Ordinary Shares (and delivered to the Rights Agent with any other securities or property surrendered as part of applicable Earnout Shares and Earnings thereon) (collectively, the “CVR Property”) to the CVR Holders, (ii) the amount and type(s) of CVR Property to be issued to each Qualifying CVR Holder for each CVR held in connection with such CVR Payment, and (iii) the requirements to become a Qualifying CVR Holder with respect to such CVR Payment and instructions for providing such information. **Upon delivery of the CVR Payment Notice, Pubco will** (i) deliver to the Rights Agent for transfer to the applicable Qualifying CVR Holders the amount and type(s) of CVR Property as set forth in the CVR Payment Notice, and (ii) **issue a press release providing (A) the calculation of the CVR Property and the amount and type(s) of CVR Property to be issued to each holder of a CVR in connection with such final determination and (B) the requirements to become a Qualifying CVR Holder**, including if determined necessary or appropriate by Pubco, a record date for CVR Holders to receive the CVR Payment."

SPAC_Time

'[In connection with the Business Combination, holders of JWAC Common Stock who did not redeem their shares](https://www.sec.gov/Archives/edgar/data/1957413/000149315224017246/form20-f.htm#:~:text=In%20connection%20with%20the%20Business%20Combination%2C%20holders%20of%20JWAC%20Common%20Stock%20who%20did%20not%20redeem%20their%20shares) received a contingent value right (“CVR”) **for each share of JWAC Common Stock that was not redeemed**. In the event that the Earnout criteria (as described below) are not met by the Company, the Sellers shall forfeit a portion of their ordinary shares, representing an adjustment to the consideration provided to the Sellers, and the Company will issue an equal amount of ordinary shares to the CVR holders on a pro rata basis. Holders of privately placed JWAC Common Stock and Class B Common Stock have waived their rights to receive CVRs for those privately placed shares. At the Closing, holders holding 12,499,295 shares of JWAC Common Stock exercised their redemption right and there were 1,300,705 shares of JWAC Common Stock held by public shareholders. As a result, **a total of 1,300,705 CVRs were issued**. Pursuant to the terms of the BCA, **the issuance of 64,084,889 ordinary shares to certain Sellers who are earnout participants** (the “Earnout Participants”), is subject to an Earnout equal in value to Six Hundred Seventy Four Million Dollars ($674,000,000) (such ordinary shares, subject to equitable adjustment for share splits, share dividends, combinations, recapitalizations and the like after the Closing, including to account for any equity securities into which such shares are exchanged or converted, and together with the earnings thereof, the “Earnout Shares”). The Earnout Shares will vest based on either meeting the criteria relating to (i) consolidated gross revenues or (ii) the closing price of the Company’s ordinary shares, and will vest in three tranches consisting of **up to 30% for 2023, 30% for 2024, and any remaining unvested amount for 2025** (in each case without giving effect to any prior surrenders of Earnout Shares and together with any Earnings as defined in the Business Combination Agreement), as described as follows:" ● The first tranche shall (i) vest proportionately based on the consolidated gross revenues of the Company (including the period prior to Closing) as set forth in the audited annual financial statements included in Form 20-F filed with the SEC for the calendar year ended December 31, 2023 (as adjusted for a fixed 6.5-to-1 Chinese yuan renminbi to U.S. dollar exchange rate) in excess of $528,000,000, up to a maximum of 100% of the first tranche at $801,000,000 in consolidated gross revenues, or alternatively (ii) vest for 100% of the first tranche if the Company’s ordinary shares on Nasdaq trade at least $13.00 per share (as equitably adjusted for share splits, share capitalizations, share consolidations, subdivisions, share dividends, reorganizations, recapitalizations and the like) for at least twenty (20) out of thirty (30) trading days, through and including the thirtieth (30th) Trading day after the date on which the Company files an annual report with the SEC on Form 20-F (such trading criteria being collectively the “Trading Criteria”)." If reading that correctly, 30% of 64,084,889 shares, or 19,225,466 shares, would be divided among 1,300,705 CVRs, or about 14.78 shares. Which matches your estimate. However, this only applies if you have the ***private*** CVRs in your portfolio, correct? " one ***private*** [contingent value right of Pubco](https://www.sec.gov/Archives/edgar/data/1957413/000149315223020432/form6-k.htm#:~:text=contingent%20value%20right%20of%20Pubco) (a “CVR”); " So only people who held JWAC through the completion of the business combination with CJET have CVRs, which are a private security in their portfolio? "[Pursuant to the CVR Agreement](https://www.sec.gov/Archives/edgar/data/1957413/000149315223020432/form6-k.htm#:~:text=Pursuant%20to%20the%20CVR%20Agreement), **the CVRs are not transferrable except for certain limited permitted transfers.**"

nefarious_indeed

CVI Signals & Forecast There are few to no technical positive signals at the moment. The CVR Energy stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $32.39 and $34.81. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -21.93%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

ErinG2021

XOM & CVR both posted lower Q1 profits

haasisgreat

Your comment shows full well that you didn’t read the report. No one will blame the pilots CRM if they did not contribute to the crash. The report already state which part of CRM they lacked. ‘The lack of thrust reduction aggravated the difficulties encountered by the crew to control the aircraft throughout the remainder of the flight. During this phase, besides the destabilising cockpit environment linked to the activation of the stick shaker and a Master Caution immediately after take-off, coordination and communication between the Captain and the F/O were very limited and insufficient. There was no discussion or diagnosis with respect to the nature of the events on board. The situational awareness, problem solving and decision making were therefore deeply impacted. The FO’s lack of proactivity, which comes out from the CVR transcripts, seems to show that he was overwhelmed by the events on board from the moment the stick shaker triggered.’ You just cannot accept the fact that the pilot was part of the issue that caused the crash. And if you’re saying that the situation is not salvageable then the pilot of the lionair plane before the crash managed to recover the plane and continue to fly the plane from Bali to Jakarta and they landed safely.

JackCrainium

UAN - CVR Partners - mlp under $1Billion current valuation ignored by hedgefunds and market makers - currently trading around $78.00 per unit - recently put on the market by Carl Icahn who needs to raise cash - potential upside to $250.00 per unit……

unclefire

The 787 has been around quite a while and generally safe. This is strange AF. Pilot lost all instruments and it took a dive? This could also be a pilot screwed up. CVR and data recorder will tell the story assuming they’re smart enough to retrieve it unlike the Alaska air thing where the cvr got overwritten bc they didn’t pull the breaker.

SPAC_Time

[8-K filing](https://www.sec.gov/Archives/edgar/data/1871745/000119312524009752/d113901d8k.htm) [Investor Presentation](https://www.sec.gov/Archives/edgar/data/1871745/000119312524009752/d113901dex992.htm) "[At the Effective Time, unless otherwise amended by the DSAQ Warrant Amendment](https://www.sec.gov/Archives/edgar/data/1871745/000119312524009752/d113901d8k.htm#:~:text=At%20the%20Effective%20Time%2C%20unless%20otherwise%20amended%20by%20the%20DSAQ%20Warrant%20Amendment), without any further action, each warrant of the Company that is outstanding immediately prior to the Effective Time shall remain outstanding but shall be assumed by PubCo and automatically adjusted to become (A) with respect to each public warrant of the Company, one (1) public warrant of PubCo and (B) with respect to each private placement warrant of the Company, one (1) private placement warrant of PubCo, each of which shall be subject to substantially the same terms and conditions applicable prior to such conversion; except that each such warrant shall be exercisable (or will become exercisable in accordance with its terms) for (i) one (1) PubCo Class A Ordinary Share, (ii) one (1) CVR I, (iii) one (1) CVR II and (iv) one (1) CVR III, in lieu of DSAQ Class A Shares (subject to the PubCo warrant agreement). **If the DSAQ Warrant Amendment is approved, then immediately prior to the Effective Time, each warrant of the Company will automatically convert into one-fifth (1/5) of one DSAQ Class A Share (with no fractional shares being issued if less than five (5) warrants are held).** " DAQW warrants are trading on OTC Pink as DSAQW.

tomoldbury

I don’t think the CVR will change the understanding of this accident.

Budget-Push7084

And they rightly should. Pilots didn’t stop the CVR recording after landing. Shit just sat there on the runway recording the ambient noise until the 2 hr overwrite was reached.

Bloodybubble86

So I chatted with the support cause it was super confusing. In the end the positions got closed automatically at aquisition rate so around 1.20 two day ago. But what I was super confused about is that the ZYNE stock is still in my porfolio but with a 20€ per stock value. Turns out it's CVR (contingent value right, had to look it up and it's very confusing). Even Etoro support looked lost: Me: I have this weird ZYNE.CVR stock Me: can I close it? (5 min later) Support: CVRs will not be available for trading, and they may not hold a tangible market value at this time. CVRs offer potential benefits contingent upon specific future events, and the value of CVRs depends on various factors, including the occurrence of predefined events and external market conditions. () We continue to monitor this event and will provide updates to all CVR holders as soon as we have more information. Me: So I can't close it? Support: Not at the moment. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ So I virtually got a good amount of money, but I can't close the position and I'm also currently unable to know if I will ever be able to cash it out.

CardinalNumber

They're not shares and you cannot sell them. https://www.sec.gov/Archives/edgar/data/1485003/000148500323000101/sesnformspecialcashdividen.htm > Sesen Bio stockholders of record on March 7, 20223 will also be issued one Contingent Value Right (“CVR”) for each outstanding share of Sesen Bio common stock, representing the right to receive any potential proceeds from the sale of Vicineum and Sesen Bio’s preclinical assets prior to March 31, 2027 and any proceeds from the potential milestone payment under the Roche Asset Purchase Agreement.

shortsqueeze99

Since AVTX already sold their drugs to another company do they even own their pipeline? I think buying AVTX would be basically buying a CVR since the company is basically relying on achieving the milestone payments to becoming worth anything

CardinalNumber

It means you need to wait. https://neovasc.com/newsreleases/shockwave-medical-to-acquire-neovasc/ > Each CVR will pay: (i) US $12.00 if the Milestone is achieved on or prior to June 30, 2026, (ii) US $8.00 if the Milestone is achieved during the period beginning on July 1, 2026 and ending on December 31, 2026 or (iii) US $4.00 if the Milestone is achieved during the period beginning on January 1, 2027 and ending on December 31, 2027. And the Milestone is FDA premarket approval to market the Neovasc Reducer in the United States for treatment of angina. You're waiting for that.

CardinalNumber

https://www.nasdaq.com/articles/sun-pharma-to-acquire-concert-pharma "[...] stockholders will also receive a non-tradeable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share of common stock in cash, payable upon deuruxolitinib achieving certain net sales milestones within specified periods." Non-tradeable means it cannot be traded. And as for the payout, well, [I googled the odds of that for you too](https://media.discordapp.net/attachments/326210299621539840/1146238785865121824/Screenshot_20230829_202326_Chrome.jpg).

VicSeeg89

Can anyone explain how a company like CVR Partners (UAN) can offer a 31% dividend? Seems too good to be true...

Zachaca2021

UAN CVR Partners (35% yield)- you would potentially have total $214k at the end of year 2.

colts24788

Guys I’ve got 1k USD what should I do with XOM/CVR?

tigeroftrades

The other jucy dividend one is the nitrogen fertilizer company CVR // $UAN. I am waiting to be paid $10.43 "per share" dividend on May 22nd. Ex-div date was May 12th. I like $ZIM's dividends but since it is an ADR, they cut 25% tax. I don't think $UAN will do that.

works_best_alone

>What is the potential future of SVBQ stock? There is no future. The bank is bankrupt, the assets have already been sold off to other banks. There's nothing left for shareholders. >I also had some ABMD stock. It got acquired buy J&J, but the stock converted to ABMD.CVB which is also very low in price, not sure if it is tradable. Would appreciate if someone could explain what are the potentials there? Here's some info from JNJ about this acquisition: [https://www.jnj.com/johnson-johnson-to-acquire-abiomed](https://www.jnj.com/johnson-johnson-to-acquire-abiomed) From the sound of it, your shares of ABMD were purchased by JNJ and you should have received cash for your shares. You also received a "non-tradeable contingent value right (CVR) entitling the holder to receive up to $35.00 per share in cash if certain commercial and clinical milestones are achieved." The milestones are: >$17.50 per share, payable if net sales for Abiomed products exceeds $3.7 billion during Johnson & Johnson’s fiscal second quarter of 2027 through fiscal first quarter of 2028, or if this threshold is not met during this period and is subsequently met during any rolling four quarter period up to the end of Johnson & Johnson’s fiscal first quarter of 2029, $8.75 per share; $7.50 per share payable upon FDA premarket application approval of the use of Impella® products in STEMI patients without cardiogenic shock by January 1, 2028; and $10.00 per share payable upon the first publication of a Class I recommendation for the use of Impella® products in high risk PCI or STEMI with or without cardiogenic shock within four years from their respective clinical endpoint publication dates, but in all cases no later than December 31, 2029. So, by continuing to hold this you will potentially receive a further $35 per share if these milestones are achieved.

100gecs-

Just in case you were curious; >Thank you for contacting IBKR Client Services. >Your ADRE position can be viewed on your statement on April 6, 2023. There was a Cash and stock merger for the position. The ADRE.ESC shares are in Escrow. >Any symbol ending in ".ESC" or ".CVR" represents a non-tradable Escrow entitlement (potential future distribution) resulting from a corporation action, for which there is no ETA on a payment (if any) and any updates regarding the situation would be announced by the company and/or their transfer agent. The position cannot be removed. Holders will retain the position in the account until the position allocation is made (if any further adjustments are needed) or until the position is removed as worthless by the Depository.

ImhereforyourDD

Sorry bro, it isn’t gonna be good. It’ll happen, just don’t know when. It probably already has, they are just trying to figure out what to give you. I have 600 shares of 74683CVR018 or something. Market value .001. I can’t even get TDA to remove it. Just sits there like a stupid assent with no worth. And will until I die or close the account Long story, years ago.

AlfalphaSupreme

How'd you come to the $1.1 per CVR? I think it's a bit lower than that.

ChemistryPuzzled682

Deadline for some sale of the legacy RTTR stuff is May 22. 2023. If your CVRs are gunna be worth anything or worthless, you'll know in a few months. Source, RTTR CVR SEC Filings: "Holders of record of Company common stock as of immediately before the time the Reverse Stock Split (described below) and Merger were consummated are entitled to receive a pro rata distribution of nontransferable contingent value rights (“CVRs”) from the Company. The CVRs will provide their holders with potential cash payment rights to a pro rata portion of the net proceeds, if any, from any “Legacy Monetization,” which means the sale, license, transfer, spin-off or other monetizing event, before May 22, 2023, of all or any part of the Company’s intellectual property associated with the Company’s legacy business of developing therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases (the “Legacy Technology”)."

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **25,109,770** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

GTOld

Yes, worth investigating $UAN (CVR Partners, LP) they should be set for a couple of good years ahead. Both facilities have recently completed their bi-annual maintenance (turnarounds), so production should be near rated capacity. Lots of expensive debt has been paid off. Feedstock of gas & coke is cheap. Quarterly distributions (not dividends) should be generous from now on. 4th quarter results due on the 21st Feb, goes ex-distro early March. But please read up about MLPs & the tax implications before investing.

Ecstatic-Passage-113

CVR stands for contract value rate. You get those given to you when a company gets acquired. If at some point you are due future compensation then it's dispensed via that. Most of the time it ends up being nothing though which is why it disappeared.

aerodynamic_AB

I did not post CVR bot

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **25,109,770** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

Working_onit

1). That's not true at all - oil prices were well over $100 for a lot of last year and were only kept on check with SPR releases. 2). Why would anybody inveat billions of dollars in US refining capacity today? You know we already produce more refined products in the US than we consume - right? 3). Why is the government heavily subsidizing renewable diesel which reduces diesel refining capacity by 60-75% when compared to Petroleum? Do you even know why the bottleneck WAS refining? Because European nat gas prices were too high making Europe short on refining, China was refusing to export refined product despite having spare refining capacity, we lost Russia's refined product exports much more than crude oil, commodity flows became less efficient and chaotic due to the war, and a lot of refining capacity got permenantly shut in due to hurricane damage and a weak supply outlook during the pandemic. The Middle East and Latin America are investing heavily in refining capacity. But why would an American company build a refinery today? It's a couple billion dollar investment, takes multiple years, historical refining margins are marginal, and you have a whole wing of the political system in America dancing on the oil industry's "grave" simultaneously demanding they never invest capital in oil again and subsidizing the shit out of EVs and blaming oil companies for high prices for not investing enough. Anyways, ever heard of Delek? CVR? Hunt? PBF? CHS? Sinclair Oil? United Refining? PDV? Goodway Refining, Vertex Energy, Petro Star, Flint Hills Resources? Kern Oil & Refining co, San Joaquin Refining co? Greka Energy, world Oil corp, Suncor, Drlaware City Refining co, Nustar Asphalt refining, Par Hawaii Refining, Countrymark Co-op, Calimet Specialty Products, Calcaseiu refining, etc... That's not nearly all of the companies that I bet you've never heard of that own one or more refineries in the US. Again, you have no idea what you are talking about. But I'm sure the answer is really simple.

creekjumper90

Thanks for this. Very bullish on Lantheus, have been since they bought Progenics! Bummer it's only a $1 per CVR, was hoping for a windfall!

Lack_Visual

Pylarify is such a success (prob. > 500m sales in 2022), that the CVR payout for 2022 (to be paid I guess in Q1 23) is the only one we’ll get (see SEC filings explaining the cap in payout). I believe the payout will be around 1.1 $ per CVR

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **30,604,646** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

CardinalNumber

You mean CVR not DVR. Contingent Value Rights. https://www.globenewswire.com/news-release/2019/09/30/1922198/0/en/Dova-Pharmaceuticals-to-be-Acquired-by-Swedish-Orphan-Biovitrum-AB-Sobi.html > Dova stockholders will be offered an upfront payment for $27.50 per share in cash, along with one non-tradeable Contingent Value Right (CVR) that entitles them to an additional $1.50 per share in cash upon regulatory approval of DOPTELET for the treatment of chemotherapy-induced thrombocytopenia (CIT) I didn't dig through what they sent the SEC but unless there's a date of expiration, there's fuck all you or anyone else can do to get rid if it before that thing they wanted approved gets the green check.

MetaphoricalMouse

Contingent Value Right (“CVR”) to be issued to Better World stockholders who do not redeem their shares will provide downside protection ranging from approximately $4.00 to $6.00 per share, depending on the level of redemptions and the duration of the CVR period. well that’s interesting

pvsocialmedia

That's one of the latest interviews where he's giving a bearish outlook on the market. Anything specific to him claiming CVR as his favorite stock?

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **30604646** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

TomETF

so assuming that the deal goes through, holding the stock until the buyout closes will entitle you to a future non tradeable CVR of 35$/share cash. Will the Abiomed shares stop existing?

brianmcg321

Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion which includes cash acquired. Abiomed shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $35.00 per share in cash if certain commercial and clinical milestones are achieved.

The-BlackLotus

Thoughts on CVR Energy?

MaximusBit21

CVR Energy - any thoughts on this one?

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **30604646** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **30604646** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.

CardinalNumber

They're not transferable. That's part of the CVR Agreement (10-1 attachment in the link I posted earlier) Can't be sold, transferred, etc.

lipmanz

They asked Icahn to name his top stock pick he picked CVR which he owns over 82% of the shares 😂😂😂

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: CVR. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.

GTOld

US fert stocks. US has 'relatively cheap' natural gas compared to Europe, Ammonia based ferts are very profitable to produce in the US. Europe is currently shutting production facilities down. US may be shipping urea & ammonia over to Europe for further processing into fertilizers. Expect a bull cycle in US fertilizer firms for 3-5 years. I'm long CVR-Partners (UAN) but CF, MOS, NTR would also be good choices.

correzzola

by combined company My question is : is GEmini therpeutic going to be delisted ? I own 9000 shares . What gonna happened to my share ? What’s CVR? Is this merging good for my position or bad Please help

correzzola

by combined company My question is : is GMTX going to be delisted ? I own 9000 shares . What gonna happened to my share ? What’s CVR? Is this merging good for my position or bad Please help

correzzola

by combined company My question is : is GMTX going to be delisted ? I own 9000 shares . What gonna happened to my share ? What’s CVR? Is this merging good for my position or bad Please help

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: CVR. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.

friedbymoonlight

CVR Energy also announced a second quarter 2022 cash dividend of 40 cents per share. In addition, the Company announced a special dividend of $2.60 per share. The quarterly and special dividends, as declared by CVR Energy’s Board of Directors, will be paid on August 22, 2022, to stockholders of record as of August 12, 2022. Today, CVR Partners announced that the Board of Directors of its general partner declared a second quarter 2022 cash distribution of $10.05 per common unit, which will be paid on August 22, 2022, to common unitholders of record as of August 12, 2022. Is this 13$ of dividends on a 30$ stock? Why would they do this?

7FigureMarketer

I'll just pipe in on this as a marketer that works with a bunch of companies and networks with a lot of marketing executives. I don't even need to look at the current price or the mountain of data you suggested to know where FB is headed; I use it every day for multiple clients. Here's the reality. 1.) Price: Costs on FB have risen over 5x since last year. Typically you'd think "wow, that's fucking great, they're making WAY more money!" - but you'd be wrong. See, the prices may be higher but companies are spending far less and in some cases, pulling out completely. I myself have watched 6 figure monthly budgets go to almost $0 spend and pulling out to try other platforms. 2.) Targeting: FB took away all of our tools. It's so difficult to express my frustration here, and if there are other marketers in this sub they'll know what I mean, but, FB cut out 99% of our "good" targeting options. Yes, we can still target you by A/S/L and we can still retarget you if you hit our site (at a drastically increased price!) however, we can no longer target Stacy the 36 year old MILF that likes Botox. We actually can't target anything in healthcare anymore. Gone are the options to select "people who like botox" or "american diabetes association"; with no targeting alternative provided. But, wait. What if we wanted to target someone for a financial offer like a credit card? Nope. You're now in a "special" category. Limited reach for your ads, higher price. You can do it, sure, but gooood fucking luck getting approval on the ad unless you're a big brand with a huge budget. 3.) ROI: Yes, there's overlap on all 3. In the end ROI is what matters, regardless of your industry or vertical. It's becoming next-to-impossible to find ROI at scale, and if by chance you do manage to strike that elusive formula between a reasonable CPM, a high CTR and high conversion rate (CVR); it doesn't last. This wasn't true for the last 10+ years. You had endless targeting options, cheap clicks and medium-level-intent. It was good enough to scale if you were a decent marketer. Now, no level of skill is going help you. You either have a slam dunk offer that everyone is clamoring for, sharing with friends and basically leveraging their entire network to give you free organic traffic - or you fail. And you will 10 times out of 10 fail without it. You could give away free fucking money on that platform and FB would still charge you $0.10 per impression and only show your ad below the fold! It's so beyond ridiculous. And this leads me to the nail in the coffin; ***brand dollars***. FB has not-so-subtly focused on big brand accounts for the last 10 years. Slowly pulling in billions from the likes of the insurance carriers, pharma, politicians and auto manufacturers of the world. Once conversion rates drop and prices go up, ROI plummets. There's only so many negative quarters a big brand, or advertising firm is going to take before they have to pull the plug. I predict companies like GM will once again say they are ditching [FB like they did back in 2012](https://www.nytimes.com/2012/05/16/business/media/gm-to-quit-facebook-ad-campaign-worth-10-million-a-year.html) Then more major advertisers will pile on. \--- The worst part of this is that it wasn't even Facebook's fault. **Apple killed Facebook**. Right up until iOS14 hit things were going smooth. Companies were spending billions because they were making billions. Now? They aren't seeing positive ROI's, and if that wasn't enough you've got a pending recession, decreased funding, lower stock prices and companies have to cut something. The first to go is...well the interns and sales teams, but after that? Marketing budgets. Why would you even bother keeping a marketing budget that isn't producing at least breakeven? You wouldn't. So, what IS happening? **We're all shifting back to Google and testing TikTok.** FB as an ad platform is NOT producing like it used to. Plain and simple. You can only fight it for so many quarters before C-levels shut that shit down. I was a longtime proponent of FB's future, but not anymore. The Metaverse is just about the only thing that can save them because between Apple fucking their shit up and the FTC cracking down on their "creepy", possibly unethical tracking tactics, it's just a matter of time before they lose every bit of what made them such a great platform.

SnooPandas4165

Right. This should all be considered when buying real estate as investment. It is not that complicated. Vacancy and eviction should be part of your models when you buy a property. Use leverage sure but forecast conservatively and don’t buy unless there is a substantial margin of safety. Also consider other factors: can you rent high end rentals to super qualified tenants ie 2 income families? Can you rent low end to government programs like CVR in NY where govt pays 50-80% of rent direct to you and tenant pays the rest? This way even if the tenant defaults you usually have enough to cover costs. Leverage is key to real estate. Think , think , think. Then apply leverage… wisely.

EzMoneyBois

1) All commodities are falling ATM because crude oil prices have also been falling. 2) UAN paid out a much smaller distribution this quarter, using much of their earnings to reduce their debt. This looks unfavorable in the eyes of investors, but is actually greatly beneficial and a smart decision by CVR Partner's Committee. 3) Demand for fertilizer usually reduces in the Spring after planting season is over. Naturally, this also causes fertilizer prices to decline, and consequently the value of agricultural stocks to dip. 4) Virtually nothing prospers in a market hampered by recession fears. That being stated, the company itself has tremendous upcoming potential. Despite market irrationalities, the situations with corn & food shortages are not going to improve in the upcoming years.

Brandon2874

Up recently, but another refinery play CVR Energy, Inc., together with its subsidiaries, engages in the petroleum refining and nitrogen fertilizer manufacturing activities in the United States. It operates in two segments, Petroleum and Nitrogen Fertilizer. The Petroleum segment refines and markets gasoline, diesel fuel, and other refined products. It also owns and operates a coking medium-sour crude oil refinery in southeast Kansas; and a crude oil refinery in Wynnewood, Oklahoma, as well as supporting logistics assets. This segment primarily serves retailers, railroads, farm co-operatives, and other refiners/marketers. The Nitrogen Fertilizer segment owns and operates a nitrogen fertilizer plant in North America that utilizes a pet coke gasification process to produce nitrogen fertilizer products; and a nitrogen fertilizer facility in East Dubuque, Illinois that produces nitrogen fertilizers in the form of ammonia and urea ammonium nitrate (UAN). It primarily markets UAN products to agricultural customers; and ammonia products to agricultural and industrial customers. The company was founded in 1906 and is headquartered in Sugar Land, Texas. CVR Energy, Inc. is a subsidiary of Icahn Enterprises L.P.

putridstench

Uncle Carl has his fingers in lots of companies.... CVR Energy ($CVI) is the one I'm most interested in at the moment because it is the master partner of CVR Partners ($UAN) which is one of the very few nitrogen fertilizer producers in the US.

SPAC_Time

Global SPAC Partners GLSPT GLSPW and Gorilla Technology Group filed a long 8-K with details on amendments to the business combination and subscription agreements. GLSPT holders who do not redeem will receive new "contingent value rights ( CVR )", which will be good for pro-rata rights to receive additional stock based on financial performance. GLSPT PIPE subscribers will be allowed to reduce their PIPE commitments from $50.5 million to $30.3 million. [More details here if interested](https://www.reddit.com/r/Spacstocks/comments/ushypi/global_spac_partners_and_gorilla_technology_group/). [New Investor Presentation](https://www.sec.gov/Archives/edgar/data/1821169/000121390022027836/ea160217ex99-1_globalspac.htm) with updated information.

OPINION_IS_UNPOPULAR

!ticker common CVR

VisualMod

I am a bot. You submitted a picture of a banned ticker, CVR. The market cap of CVR is **30604646** This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1 billion-ish market cap and not related to crypto/pennies/OTC.

GTOld

I guess because there's huge demand & little supply of N-based fertilizers. Before gas prices became an issue there were many factors that were leading to a bullish market for fertilizer stocks. Poor weather related crop failures globally, anti-dumping import restrictions being implemented in the US, depletion of grain stockpiles globally. Recent war related events have only amplified the existing issues. I'm long on CVR Partners (UAN) as they're predicted to pump out $40/annum in distributions for the next 3-4 years. Unit price is around $150-$160, so that's a 25% yield. I expect that the unit price to move to $300-$400 within the 12 months once folk become more aware of the consistently high distributions.

VisualMod

I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: CVR. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.

ApeRidingLittleRed

stock, but still: look up NYSE-listed CVR Partners (UAN): fertilizers [https://www.nasdaq.com/de/market-activity/stocks/uan](https://www.nasdaq.com/de/market-activity/stocks/uan) https://www.cvrpartnerslp.com/ Disclosure: will buy in next week Disclosure: i find tweeters contrarian8888 and Toronto242M interesting No financial advice, for some time commodities will remain valuable.